Page last updated: 2024-08-21

benzoxazoles and pitavastatin

benzoxazoles has been researched along with pitavastatin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Arai, H; Araki, E; Ishibashi, S; Suganami, H; Yamashita, S; Yokote, K1
Akazawa, K; Ito, H; Kimura, T; Kondo, M; Miura, D; Miyoshi, T; Nakamura, K; Ohno, Y; Ohtsuka, H; Yoshida, M1
Abe, H; Goto, R; Kamimura, H; Kamimura, K; Kimura, A; Morita, S; Oda, C; Ohkoshi-Yamada, M; Owaki, T; Sakai, N; Sakamaki, A; Shibata, O; Shinagawa-Kobayashi, Y; Terai, S; Yokoo, T1

Trials

1 trial(s) available for benzoxazoles and pitavastatin

ArticleYear
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia.
    Atherosclerosis, 2017, Volume: 261

    Topics: Adult; Aged; Benzoxazoles; Biomarkers; Butyrates; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Japan; Male; Middle Aged; PPAR alpha; Quinolines; Signal Transduction; Time Factors; Treatment Outcome; Triglycerides; Young Adult

2017

Other Studies

2 other study(ies) available for benzoxazoles and pitavastatin

ArticleYear
Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet.
    Cardiovascular diabetology, 2020, 09-26, Volume: 19, Issue:1

    Topics: Animals; Aorta, Thoracic; Benzoxazoles; Blood Pressure; Butyrates; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Chylomicrons; Diet, High-Fat; Drug Therapy, Combination; Endothelium; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Insulin Resistance; Lipoproteins, HDL; PPAR alpha; Quinolines; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Triglycerides; Vasodilation

2020
Effects of a novel selective PPARα modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model.
    Biochemical and biophysical research communications, 2022, 03-12, Volume: 596

    Topics: Animal Fins; Animals; Animals, Genetically Modified; Benzhydryl Compounds; Benzoxazoles; Butyrates; Diet, High-Fat; Disease Models, Animal; Exome Sequencing; Gene Ontology; Glucosides; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Non-alcoholic Fatty Liver Disease; Oryzias; PPAR alpha; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Glucose Transporter 2 Inhibitors; Transcriptome

2022
chemdatabank.com